Literature DB >> 19238304

Prediction of hip and other osteoporotic fractures from hip geometry in a large clinical cohort.

W D Leslie1, P S Pahlavan, J F Tsang, L M Lix.   

Abstract

SUMMARY: Incident hip fractures and non-hip osteoporotic fractures were studied in 30,953 women during mean 3.7 years of observation. Hip axis length (HAL) and strength index (SI) made a small but statistically significant contribution to hip fracture prediction that was independent of age and hip bone density.
INTRODUCTION: It is uncertain whether bone geometric measures improve fracture prediction independent of conventional areal bone mineral density (BMD).
METHODS: Women aged > or =50 years with hip dual-energy x-ray absorptiometry were identified from the regionally based database in the Province of Manitoba, Canada. Scans were reprocessed to derive parameters of hip bone geometry. Incident hip fractures (N = 270) and non-hip osteoporotic fractures (N = 1,347) were identified during mean 3.7 years of observation.
RESULTS: HAL was greater in both hip and non-hip fracture cases than in non-fracture cases, whereas cross-sectional moment of inertia, cross-sectional area, and femoral SI were all significantly less. After adjustment for total hip BMD, HAL [hazard ratio (HR) 1.22 per SD increase, 95% CI 1.07-1.38] and SI (HR 1.21 per SD decrease, 95% CI 1.07-1.37) were independent predictors of hip fractures but not of non-hip fractures. When both HAL and SI were added to a model containing age and total hip BMD, there was a small improvement in hip fracture prediction (ROC area under the curve 0.832 +/- 0.013 vs 0.823 +/- 0.013; P = 0.001).
CONCLUSIONS: HAL and SI made a small but statistically significant contribution to hip fracture prediction that was independent of age and BMD measurement.

Entities:  

Mesh:

Year:  2009        PMID: 19238304     DOI: 10.1007/s00198-009-0874-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  31 in total

1.  Revisiting the Manitoba Centre for Health Policy and Evaluation and its population-based health information system.

Authors:  N P Roos; E Shapiro
Journal:  Med Care       Date:  1999-06       Impact factor: 2.983

2.  Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence.

Authors:  Neil Binkley; Gary M Kiebzak; E Michael Lewiecki; Diane Krueger; Ronald E Gangnon; Paul D Miller; John A Shepherd; Marc K Drezner
Journal:  J Bone Miner Res       Date:  2004-11-16       Impact factor: 6.741

3.  The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada.

Authors:  J D Adachi; G Loannidis; C Berger; L Joseph; A Papaioannou; L Pickard; E A Papadimitropoulos; W Hopman; S Poliquin; J C Prior; D A Hanley; W P Olszynski; T Anastassiades; J P Brown; T Murray; S A Jackson; A Tenenhouse
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

4.  Current and projected rates of hip fracture in Canada.

Authors:  E A Papadimitropoulos; P C Coyte; R G Josse; C E Greenwood
Journal:  CMAJ       Date:  1997-11-15       Impact factor: 8.262

5.  Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).

Authors:  A Tenenhouse; L Joseph; N Kreiger; S Poliquin; T M Murray; L Blondeau; C Berger; D A Hanley; J C Prior
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

6.  The use of multiple sites for the diagnosis of osteoporosis.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; J A Eisman; S Fujiwara; H Kroger; R Honkanen; L J Melton; T O'Neill; J Reeve; A Silman; A Tenenhouse
Journal:  Osteoporos Int       Date:  2006-01-10       Impact factor: 4.507

7.  The importance of spectrum bias on bone density monitoring in clinical practice.

Authors:  William D Leslie
Journal:  Bone       Date:  2006-03-13       Impact factor: 4.398

8.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

9.  BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.

Authors:  Katie L Stone; Dana G Seeley; Li-Yung Lui; Jane A Cauley; Kristine Ensrud; Warren S Browner; Michael C Nevitt; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2003-11       Impact factor: 6.741

10.  Femoral neck BMD is a strong predictor of hip fracture susceptibility in elderly men and women because it detects cortical bone instability: the Rotterdam Study.

Authors:  Fernando Rivadeneira; M Carola Zillikens; Chris Edh De Laet; Albert Hofman; André G Uitterlinden; Thomas J Beck; Huibert Ap Pols
Journal:  J Bone Miner Res       Date:  2007-11       Impact factor: 6.741

View more
  35 in total

1.  Sexual dimorphism of femoral neck cross-sectional bone geometry in athletes and non-athletes: a hip structural analysis study.

Authors:  Karen Hind; Lisa Gannon; Emma Whatley; Carlton Cooke
Journal:  J Bone Miner Metab       Date:  2011-12-13       Impact factor: 2.626

2.  Hip structural analysis in adolescent boys with anorexia nervosa and controls.

Authors:  Madhusmita Misra; Debra K Katzman; Hannah Clarke; Deirdre Snelgrove; Kathryn Brigham; Karen K Miller; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2013-05-07       Impact factor: 5.958

3.  Comparison of hip geometry, strength, and estimated fracture risk in women with anorexia nervosa and overweight/obese women.

Authors:  Katherine Neubecker Bachmann; Pouneh K Fazeli; Elizabeth A Lawson; Brian M Russell; Ariana D Riccio; Erinne Meenaghan; Anu V Gerweck; Kamryn Eddy; Tara Holmes; Mark Goldstein; Thomas Weigel; Seda Ebrahimi; Diane Mickley; Suzanne Gleysteen; Miriam A Bredella; Anne Klibanski; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

4.  Can Hip Fracture Prediction in Women be Estimated beyond Bone Mineral Density Measurement Alone?

Authors:  Piet Geusens; Tineke van Geel; Joop van den Bergh
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-04       Impact factor: 5.346

5.  Bone cross-sectional geometry in male runners, gymnasts, swimmers and non-athletic controls: a hip-structural analysis study.

Authors:  Karen Hind; Lisa Gannon; Emma Whatley; Carlton Cooke; John Truscott
Journal:  Eur J Appl Physiol       Date:  2011-05-24       Impact factor: 3.078

6.  The natural history and hip geometric changes of primary hyperparathyroidism without parathyroid surgery.

Authors:  Kyong Yeun Jung; A Ram Hong; Dong Hwa Lee; Jung Hee Kim; Kyoung Min Kim; Chan Soo Shin; Seong Yeon Kim; Sang Wan Kim
Journal:  J Bone Miner Metab       Date:  2016-04-02       Impact factor: 2.626

7.  Multisystem dysregulation and bone strength: findings from the study of midlife in the United States.

Authors:  Takahiro Mori; Arun S Karlamangla; Sharon Stein Merkin; Carolyn J Crandall; Neil Binkley; Gail A Greendale; Teresa E Seeman
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

8.  Impact of sleeve gastrectomy on hip structural analysis in adolescents and young adults with obesity.

Authors:  Madhusmita Misra; Abisayo Animashaun; Amita Bose; Vibha Singhal; Fatima Cody Stanford; Brian Carmine; Miriam A Bredella
Journal:  Surg Obes Relat Dis       Date:  2020-07-31       Impact factor: 4.734

9.  C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women's Health Across the Nation (SWAN).

Authors:  Shinya Ishii; Jane A Cauley; Gail A Greendale; Carolyn J Crandall; Michelle E Danielson; Yasuyoshi Ouchi; Arun S Karlamangla
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

10.  Hip structural analysis in adolescent and young adult oligoamenorrheic and eumenorrheic athletes and nonathletes.

Authors:  Kathryn E Ackerman; Lisa Pierce; Gabriela Guereca; Meghan Slattery; Hang Lee; Mark Goldstein; Madhusmita Misra
Journal:  J Clin Endocrinol Metab       Date:  2013-03-08       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.